RecruitingPhase 3NCT06044623

Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients

Studying Toxic dermatosis

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Region Örebro County
Principal Investigator: Antonios Valachis, Assoc Prof
Region Örebro län
Intervention: CDK 4/6 inhibitors(drug)
Enrollment: 495 enrolled
Eligibility: 70 years · All sexes
Timeline: 2024 – 2029

Study locations (12)

Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland
Fourth Oncology Department & Comprehensive Clinical Trials Center, Metropolitan Hospital, Athens, Greece
Second Department of Medical Oncology, Hygeia Hospital, Athens, Greece
Division of Oncology, Department of Medicine, University Hospital, University of Patras Medical School, Pátrai, Greece
Medical Oncology Unit, S. Andrew Hospital, Pátrai, Greece
Second Department of Medical Oncology, Euromedica General Clinic, Thessaloniki, Greece
Radiation Oncology Unit - Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy
"Sandro Pitigliani" Department of Medical Oncology, Hospital of Prato, Prato, Italy
Department of Oncology, Akershus University Hospital (AHUS), Oslo, Norway
Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain
Department of Oncology, Örebro University Hospital, Örebro, Sweden
Department of Oncology, Uppsala University Hospital, Uppsala, Sweden

Collaborators

University of Patras · University of Florence · Azienda USL Toscana Centro · Helsinki University Central Hospital · Institute for Medical Technology Assessment - the Netherlands · Security Labs Consulting Limited · Circular Economy Foundation · Universidad Nacional de Educación a Distancia · Hellenic Cooperative Oncology Group · University Hospital, Akershus · Uppsala County Council, Sweden · Hospital Clinic of Barcelona · Phaze Clinical Research & Pharma Consulting · Bröstcancerförbundet · Eunomia Ltd · University of Applied Sciences and Arts Northwestern Switzerland · CareAcross · Örebro University, Sweden

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06044623 on ClinicalTrials.gov

Other trials for Toxic dermatosis

Additional recruiting or active studies for the same condition.

See all trials for Toxic dermatosis →

← Back to all trials